JONATHAN FRAIM: Open Payments
NPI 1306818901 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,642 in 133 payments from 18 companies in 2025. Trend: 2023 $1,769 · 2024 $2,578 · 2025 $2,642
Food & beverage: $2,632Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $784 |
| Janssen Biotech, Inc. | 24 | $314 |
| UCB, Inc. | 7 | $203 |
| Novartis Pharmaceuticals Corporation | 9 | $171 |
| Incyte Corporation | 6 | $148 |
| Arcutis Biotherapeutics, Inc. | 12 | $143 |
| PFIZER INC. | 6 | $138 |
| Lilly USA, LLC | 6 | $122 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| E.R. Squibb & Sons, L.L.C. | 6 | $109 |
Products named: SKYRIZI, RINVOQ, TREMFYA, Bimzelx, DUPIXENT, OPZELURA, Zoryve, CIBINQO.
Industry payments across VA — which companies pay providers there.
